CONGRESOS 2018

ESC (European Society of Cardiology) Congress 2018
Munich, 25-29 de agosto de 2018
Tamargo J. Moderador. Expert Session: "Safety first: avoiding adverse events with new cardiovacular drugs". Ponente "Safey first: avoiding adverse events with new cardiovascular drugas - Take Home Message". Congreso: ESC (European Society of Cardiology) Congress. Munich, 25-29 de agosto de 2018.

Tamargo J. Ponente "Are regulations for generic CV drugs". Symnposium: "Are generic drugs safe in heart failure?". Congreso: ESC (European Society of Cardiology) Congress. Munich, 25-29 de agosto de 2018.

Tamargo J. Moderador. Case-based Session "Antithrombotics and cancer: challenges in clinical practice?" Congreso: ESC (European Society of Cardiology) Congress. Munich, 25-29 de agosto de 2018.

38th Meeting Spanish Society of Pharmacology y 9th Spanish Meeting of Pharmacogenetics and Pharmacogenomics
Santiago de Compostela, 18-22 de junio de 2018
PONENTE. Roundtable: Pharmacology of cardiometabolic diseases. "New therapeutic approaches in the treatment of type 2 diabetes mellitus". 38th Meeting Spanish Society of Pharmacology y 9th Spanish Meeting of Pharmacogenetics and Pharmacogenomics. Santiago de Compostela, 20 de junio, 2018.

30 Congreso Nacional de la Sociedad Española de Medicina de Urgencias y Emergencias
Toledo, 7 de junio de 2018
CONFERENCIA MAGISTRAL “El futuro de las arritmias en la fase aguda”. Los fármacos antiarrítmicos: una historia llena de futuro.

The 6th Annual Congress of the ESC WG on Cardiovascular Pharmacotherapy. EuroCVP 2018.
Tel Aviv, Israel, 13-14 de mayo de 2018.
PONENTE. "The 2018 update on blood cholesteroal treatment in coronary patients". "Drugs and treatment". European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
PONENTE. "Clinical Trials Programme all About Clinical Trials". "Traditional versus novel trial designing". European Society of Cardiology Working Group on Cardiovascular.

6ª Jornadas Nacionales Nefrourológicoas SEMERGEN
Segovia, 13 de abril de 2018
PONENTE. Mesa Redonda: Avances en vejiga hiperactiva. Nuevos fármacos. "Perfíl farmacológico de la propiverina".